MX9706967A - Indazolcarboxamidas. - Google Patents
Indazolcarboxamidas.Info
- Publication number
- MX9706967A MX9706967A MX9706967A MX9706967A MX9706967A MX 9706967 A MX9706967 A MX 9706967A MX 9706967 A MX9706967 A MX 9706967A MX 9706967 A MX9706967 A MX 9706967A MX 9706967 A MX9706967 A MX 9706967A
- Authority
- MX
- Mexico
- Prior art keywords
- indazolecarboxamides
- receptor
- dysfunction
- antagonists
- affected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Paper (AREA)
- Luminescent Compositions (AREA)
Abstract
Las indazolcarboxamidas se usan como antagonistas y agonistas parciales del receptor 5-HT4 de la serotonina y proporcionan métodos terapéuticos para el tratamiento de desordenes causados por o afectados por la disfuncion del receptor 5-HT4.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40511995A | 1995-03-16 | 1995-03-16 | |
US405119 | 1995-03-16 | ||
US405,119 | 1995-03-16 | ||
US08/485,956 US5654320A (en) | 1995-03-16 | 1995-06-07 | Indazolecarboxamides |
US08485956 | 1995-06-07 | ||
PCT/US1996/003551 WO1996033713A1 (en) | 1995-03-16 | 1996-03-14 | Indazolecarboxamides |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9706967A true MX9706967A (es) | 1997-11-29 |
MXPA97006967A MXPA97006967A (es) | 1998-07-03 |
Family
ID=
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT74992A (en) | Use of serotonin antagonist indol derivatives for producing pharmaceutical compositions using for treating fibromyalgia | |
MY131298A (en) | 5-heteroyl indole derivatives | |
MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
MY132229A (en) | Indole derivatives as 5-ht receptor antagonist | |
NO20003550L (no) | Farmasøytiske sammensetninger og anvendelse herav | |
NO944578L (no) | Eksitatoriske aminosyre reseptor antagonister | |
MX9704640A (es) | Compuesto moduladores de los receptores de los esteroides y metodos para su preparacion. | |
NZ332780A (en) | Substituted amines for the treatment of neurological and neuropsychiatric disorders | |
EA199800340A1 (ru) | Производные пиримидина как антагонисты 5нт2с | |
YU59098A (sh) | Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži | |
IL128003A0 (en) | Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies | |
HU9503826D0 (en) | Heterocycles useful as neurokinin antagonists | |
PT1666462E (pt) | Derivados de n-[1h-indol-5-il]-naftaleno-1-sulfonamida e compostos associados enquanto antagonistas do receptor 5- ht6 de serotonina para o tratamento de distúrbios do sistema nervoso central | |
NZ334029A (en) | Use of serotonin 5-HT1F agonist for the treatment of common colds or allergic rhinitis | |
TR199700956T1 (xx) | Indazolkarboksamidler. | |
NO963731L (no) | Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister | |
GR3019782T3 (en) | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents | |
AU3745795A (en) | Use of CCK-B receptor antagonists for the treatment of sleepdisorders | |
WO1993023035A3 (en) | Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease | |
AU5614198A (en) | Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors | |
MY107354A (en) | Substituted cyclohexenes as central nervous system agents | |
ATE256126T1 (de) | 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen | |
EP0976747A3 (en) | Use of 5HT-1F receptor antagonists for treating anxiety disorders | |
NO20012538D0 (no) | Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet | |
IT1294932B1 (it) | Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |